| Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma O Ekmekcioglu, A Aliyev, S Yilmaz, E Arslan, R Kaya, P Kocael, ME Erkan, ... Nuclear Medicine Communications 34 (11), 1055-1067, 2013 | 52 | 2013 |
| Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer E Arslan, TF Çermik, FDC Trabulus, ECK Talu, S Basaran Nuclear medicine communications 39 (7), 680-690, 2018 | 37 | 2018 |
| The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers AE Aksoy T, Gürsu RU, Dursun N, Çakar E, Çermik TF Mol Imaging Radionucl Ther. 29 (1), 17-24., 2020 | 21 | 2020 |
| 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT findings of bilateral knee osteoarthritis in a patient with uveal malignant melanoma ÖE Fenercioğlu, E Beyhan, N Ergül, E Arslan, TF Çermik Clinical nuclear medicine 47 (2), e144-e146, 2022 | 20 | 2022 |
| 68Ga-FAPI-04 PET/CT in selected breast cancer patients with low FDG affinity: a head-to-head comparative study G Alçın, E Arslan, T Aksoy, M Cin, ÖE Fenercioğlu, E Beyhan, N Ergül, ... Clinical Nuclear Medicine 48 (9), e420-e430, 2023 | 18 | 2023 |
| Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas ÇTF Arslan E,Aksoy T, Gündoğan C, Şen Ç, Yılmaz Tatar S, Dursun N Mol Imaging Radionucl Ther. 29 (1), 25-32, 2020 | 14 | 2020 |
| Recurrent brain metastasis of triple negative breast cancer with high uptake in 68Ga-PSMA-11 PET/CT E Arslan, N Ergül, Y Karagöz, AA Gedik, TF Çermik Clinical nuclear medicine 46 (2), e106-e108, 2021 | 11 | 2021 |
| Malignant otitis externa: how to monitor the disease in outcome estimation? AP Yigider, O Ovunc, E Arslan, AV Sunter, TF Cermik, O Yigit Medeniyet Medical Journal 36 (1), 23, 2021 | 11 | 2021 |
| Elephantiasis nostras verrucosa on the abdomen of a Turkish female patient caused by morbid obesity. GS Buyuktas D, Arslan E, Celik O, Tasan E, Demirkesen C Dermatol Online J. 16 (8), 14, 2010 | 10 | 2010 |
| Diagnostic impact of 18F-FDG PET/CT on the management of rare breast carcinomas: Apocrine and neuroendocrine carcinomas E Arslan, TF Cermik, FDC Trabulus, ECK Talu, Ş Başaran Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 38 …, 2019 | 9 | 2019 |
| The Role of 18 F-FDG PET/CT in staging of gallbladder carcinomas ÇTF Arslan Esra, Aksoy Tamer,Dursun Nevra,Gürsu Rıza Umar, Sevinç Mert Mahsuni The Turkish Journal of Gastroenterology 31 (2), 105-112, 2020 | 7 | 2020 |
| Extraction of a Foreign Body from the Breast Using Radio-guided Occult Lesion Localization (ROLL): Metallic Foreign Body in the Breast. AE Dal F, Ökmen H, Yılmaz MK, Sarı S, Nazlı MA Eur J Breast Health. 13 (3), 159-160, 2017 | 7 | 2017 |
| Preoperative localization of distal colorectal tumours S Bayrak, E Kinaci, A Ozakay, CT Bektas, AH Yardimci, E Arslan, ... Annali Italiani di Chirurgia 87 (6), 595-600, 2016 | 7 | 2016 |
| The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with … E Arslan, N Ergül, E Beyhan, ÖE Fenercioglu, R Sahin, M Cin, SB Havare, ... Nuclear Medicine Communications 44 (4), 284-290, 2023 | 6 | 2023 |
| The expression of Galectin-3 in tumor and cancer-associated fibroblasts in invasive micropapillary breast carcinomas: relationship with clinicopathologic parameters Y Çakır, CK Talu, Ö Mermut, DC Trabulus, E Arslan European Journal of Breast Health 17 (4), 341, 2021 | 6 | 2021 |
| Complex fibroadenoma mimicking breast cancer on 68Ga-FAPI-04 and 18F-FDG PET/CT G Alçin, G Tatar, MSM Koç, E Arslan, N Ergül, TF Çermik Clinical Nuclear Medicine 48 (3), e121-e123, 2023 | 5 | 2023 |
| The clinicopathologic features of 22 cases with primary invasive papillary carcinoma of the breast identified in 1153 cases with invasive breast carcinoma: single-center experience CK Talu, BY Erdem, E Arslan, MA Nazli, Y Cakir, DC Trabulus European Journal of Breast Health 18 (4), 360, 2022 | 5 | 2022 |
| Comparison of 18F-FDG and 68Ga-FAPI PET/CT in gastric Kaposi sarcoma G Tatar, E Beyhan, ÖE Fenercioğlu, E Arslan, TF Çermik Clinical Nuclear Medicine 47 (9), e596-e599, 2022 | 5 | 2022 |
| PET/CT variants and pitfalls in liver, biliary tract, gallbladder and pancreas E Arslan, TF Çermik Seminars in Nuclear Medicine 51 (5), 502-518, 2021 | 5 | 2021 |
| The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with … E Arslan, T Aksoy, FDC Trabulus, CK Talu, B Yeni, TF Çermik Nuclear Medicine Communications 41 (3), 260-268, 2020 | 5 | 2020 |
Esra Canan Kelten TaluSağlık Bilimleri Üniversitesi在 sbu.edu.tr 的电子邮件经过验证
